Ranscriptionally upregulate CD30, CD15, FGF2, and SDC1 within the untreated poor
Ranscriptionally upregulate CD30, CD15, FGF2, and SDC1 within the untreated poor outcome group. The principle subset here may be putative HRS cells or some other variant of those neoplastic cells…